ASH 2018: Dr. Chadi Nabhan on the Cost of Ibru... - CLL Support

CLL Support

23,250 members39,937 posts

ASH 2018: Dr. Chadi Nabhan on the Cost of Ibrutinib vs. Chemo vs Chemoimmunotherapy in CLL and on way too much chemo being used.

bkoffman profile image
bkoffmanCLL CURE Hero
12 Replies

Hi,

If you have been on our website recently you have already met Dr. Nabhan talking about patient reported outcomes. This time at ASH 2018, we also discussed his innovative research using claims data from 2014- 2017 on the total cost of care for CLL patients who took ibrutinib versus chemotherapy or chemo-immunotherapy (CT/CIT).

Guess what- The total cost is cheaper with ibrutinib.

But here is the really scary and depressing part.

1,464 patients received chemotherapy alone. This is a huge concern as there is no role for chemotherapy on its own in CLL. In fact, there is very little role for chemo-immunotherapy.

The trial was designed to look at the economic impact of drug choice, but to his credit Dr. Nabhan highlights his finding about the lousy treatment too many patients are still getting.

Here is the link my ASH 2018 interview: cllsociety.org/2019/08/ash-...

I have more coming from Dr. Nabhan from ASH soon. I like doing stuff that isn’t just the science research but the real world data

Stay strong.

We are all in this together.

Brian

Brian Koffman MDCM DCFP, DABFM, MS Ed

Co-Founder, Executive VP and Chief Medical Officer

CLL Society, Inc

cllsociety.org

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
12 Replies
sbkris1 profile image
sbkris1

Thank you for sharing this important info!

Benlewis profile image
Benlewis

Thanks Brian, interesting but I’m puzzled by your statement that there is no role for chemotherapy on its own in CLL. FCR is chemotherapy and still considered the “gold standard” by many CLL doctors for mutated younger patients. Am I misinterpreting something here?

PlanetaryKim profile image
PlanetaryKim in reply toBenlewis

FCR is chemo-immunotherapy, not chemo alone. The "R" is the immunotherapy.

Benlewis profile image
Benlewis in reply toPlanetaryKim

Thanks Kim

PlanetaryKim profile image
PlanetaryKim in reply toBenlewis

Any drug ending in "mab" (for monoclonal antibody) is immunotherapy, such as rituximab, obinutuzumab, or for solid tumor cancers: pembrolizumab, nivolumab, etc.

Benlewis profile image
Benlewis in reply toPlanetaryKim

I still learn a lot from this site, thanks again

bkoffman profile image
bkoffmanCLL CURE Hero in reply toBenlewis

FCR is chemo-immunotherapy. F or FC would be chemo and should never be used.

JigFettler profile image
JigFettlerVolunteer in reply tobkoffman

I am not clear about what you are saying...

FCR should not be used.

Or F and FC alone should not be used?

Jig

bkoffman profile image
bkoffmanCLL CURE Hero in reply toJigFettler

F or FC or chlorambucil or B shouldn't be used without a monoclonal antibody.

Big_Dee profile image
Big_Dee in reply tobkoffman

Hi Brian

I am glad you clarified that.

PlanetaryKim profile image
PlanetaryKim

Good work Brian! Thank you for sharing.

Smakwater profile image
Smakwater

The matrice is too often viewed as one dimensional. This is another good reason to become a knowledgable self advocate.

Good point,

JM

Not what you're looking for?

You may also like...

ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of venetoclax for CLL

Today we posted on ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of...
bkoffman profile image
CLL CURE Hero

My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.

Hi March 22, 2019 was my one year anniversary of receiving my experimental CAR-T cells in Seattle....
bkoffman profile image
CLL CURE Hero

ASH 2018: Professor Peter Hillmen on the Combination of Ibrutinib and Obinutuzumab in CLL: Timing Matters

Today we start with an important abstract from the United Kingdom that may have significant...
lankisterguy profile image
Volunteer

CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCO

Hi, Just back from a frenetic and fantastic ASH, but still have news to share from ASCO. But first...
bkoffman profile image
CLL CURE Hero

ASH 2018: Dr. Lindsey Roeker, on real world use of venetoclax for CLL (chronic lymphocytic leukemia)

Is venetoclax as safe and effective in the real world as compared to clinical trials? Read my ASH...
bkoffman profile image
CLL CURE Hero

Moderation team

See all
Newdawn profile image
NewdawnAdministrator
AussieNeil profile image
AussieNeilAdministrator
CLLerinOz profile image
CLLerinOzAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.